Ziprasidone for schizophrenia
This study is completed in Mexico. It is testing ziprasidone for schizophrenia.
Multiple locations, including Monterrey
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in Mexico. It is testing ziprasidone for schizophrenia.
Multiple locations, including MonterreyThis study was terminated in Portugal. It is testing ziprasidone for schizophrenia.
In LisbonThis study is completed in Belgium, in Germany, and in Poland. It is testing efficacy of Intravenous Esketamine for treatment-resistant depression.
Multiple locations, including DaveThis study is completed. It is testing Extended-release Oral Paliperidone for schizophrenia.
Location not clearly listedThis study is completed in the United States, in Romania, in Russia, .... It is testing investigational Drug for schizophrenia.
Multiple locations, including CerritosThis study is completed. It is testing Pharmacokinetics of ER OROS Paliperidone for Schizophrenia.
Location not clearly listedThis study is completed. It is testing pharmacokinetics of Paliperidone for Schizophrenia.
Location not clearly listedThis study is completed. It focuses on Schizophrenia.
Location not clearly listedThis study is completed in the United States. It focuses on Addiction.
In HoustonThis study is completed in the United States. It is testing relationship of Psychosocial Function With Mood Symptoms for Bipolarity.
Multiple locations, including Culver CityThis study is completed. It is testing risperidone for ADHD.
Location not clearly listedThis study is completed. It is testing risperidone for ADHD.
Location not clearly listedHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.